Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2021

Report Description


The Global Nuclear Medicine & Radio Pharmaceuticals Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Nuclear Medicine & Radio Pharmaceuticals Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Nuclear Medicine & Radio Pharmaceuticals Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Nuclear Medicine & Radio Pharmaceuticals Market product affairs. The report is at risk of project regarding this Nuclear Medicine & Radio Pharmaceuticals Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare
  • Toshiba
  • Hitachi
  • Carestream
  • Esaote
  • Shimadzu
  • TriFoil Imaging
  • Biosensors International Group Ltd

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Nuclear Medicine & Radio Pharmaceuticals related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Nuclear Medicine & Radio Pharmaceuticals Market

Nuclear Medicine & Radio Pharmaceuticals Market

Report Highlights:


The Nuclear Medicine & Radio Pharmaceuticals Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Nuclear Medicine & Radio Pharmaceuticals Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Nuclear Medicine & Radio Pharmaceuticals Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Nuclear Medicine & Radio Pharmaceuticals Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Nuclear Medicine & Radio Pharmaceuticals marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Nuclear Medicine & Radio Pharmaceuticals market using a bottom-up approach, wherein manufacturers value data for different type (Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals, Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes), of Nuclear Medicine & Radio Pharmaceuticals market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Nuclear Medicine & Radio Pharmaceuticals Market

Nuclear Medicine & Radio Pharmaceuticals Market

Key Target Audience:


  • Nuclear Medicine & Radio Pharmaceuticals market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Nuclear Medicine & Radio Pharmaceuticals market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Nuclear Medicine & Radio Pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Nuclear Medicine & Radio Pharmaceuticals market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Diagnostic Medicine: SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Medicine: Beta Emitters
  • Alpha Emitters
  • Brachytherapy Isotopes

By end-user also classify into, the Global Nuclear Medicine & Radio Pharmaceuticals market:


Global Nuclear Medicine & Radio Pharmaceuticals market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Diagnostic Applications: SPECT
  • PET.
  • Therapeutic Applications: Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors and Other Therapeutic Applications.

Highlights of this 2021-2027 Nuclear Medicine & Radio Pharmaceuticals Market Report:

  • Market dynamics, Nuclear Medicine & Radio Pharmaceuticals economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Nuclear Medicine & Radio Pharmaceuticals industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Nuclear Medicine & Radio Pharmaceuticals Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Nuclear Medicine & Radio Pharmaceuticals businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Nuclear Medicine & Radio Pharmaceuticals market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

Table of Contents

Executive Summary
1 Industry Overview of Nuclear Medicine & Radio Pharmaceuticals
1.1 Definition of Nuclear Medicine & Radio Pharmaceuticals
1.2 Nuclear Medicine & Radio Pharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Comparison by Types (2016-2027)
1.2.2 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
1.2.3 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.3 Nuclear Medicine & Radio Pharmaceuticals Segment by Applications
1.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Comparison by Applications (2016-2027)
1.3.2 Diagnostic Applications: SPECT, PET.
1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.4 Global Nuclear Medicine & Radio Pharmaceuticals Overall Market
1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue (2016-2027)
1.4.2 Global Nuclear Medicine & Radio Pharmaceuticals Production (2016-2027)
1.4.3 North America Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.4 Europe Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.5 China Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.6 Japan Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.7 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.8 India Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals
2.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
2.4 Industry Chain Structure of Nuclear Medicine & Radio Pharmaceuticals

3 Development and Manufacturing Plants Analysis of Nuclear Medicine & Radio Pharmaceuticals
3.1 Capacity and Commercial Production Date
3.2 Global Nuclear Medicine & Radio Pharmaceuticals Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Nuclear Medicine & Radio Pharmaceuticals
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Nuclear Medicine & Radio Pharmaceuticals Production and Capacity Analysis
4.2 Nuclear Medicine & Radio Pharmaceuticals Revenue Analysis
4.3 Nuclear Medicine & Radio Pharmaceuticals Price Analysis
4.4 Market Concentration Degree

5 Nuclear Medicine & Radio Pharmaceuticals Regional Market Analysis
5.1 Nuclear Medicine & Radio Pharmaceuticals Production by Regions
5.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Production by Regions
5.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions
5.2 Nuclear Medicine & Radio Pharmaceuticals Consumption by Regions
5.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.3.1 North America Nuclear Medicine & Radio Pharmaceuticals Production
5.3.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.4 Europe Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.4.1 Europe Nuclear Medicine & Radio Pharmaceuticals Production
5.4.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.5 China Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.5.1 China Nuclear Medicine & Radio Pharmaceuticals Production
5.5.2 China Nuclear Medicine & Radio Pharmaceuticals Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.6 Japan Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.6.1 Japan Nuclear Medicine & Radio Pharmaceuticals Production
5.6.2 Japan Nuclear Medicine & Radio Pharmaceuticals Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.7 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.7.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production
5.7.2 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.8 India Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.8.1 India Nuclear Medicine & Radio Pharmaceuticals Production
5.8.2 India Nuclear Medicine & Radio Pharmaceuticals Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Nuclear Medicine & Radio Pharmaceuticals Import and Export

6 Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Type)
6.1 Global Nuclear Medicine & Radio Pharmaceuticals Production by Type
6.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Type
6.3 Nuclear Medicine & Radio Pharmaceuticals Price by Type

7 Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Application)
7.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Application
7.2 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Application (2016-2021)

8 Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers Analysis
8.1 GE Healthcare
8.1.1 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.1.2 GE Healthcare Product Introduction, Application and Specification
8.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.1.4 Main Business and Markets Served
8.2 Philips Healthcare
8.2.1 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.2.2 Philips Healthcare Product Introduction, Application and Specification
8.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.2.4 Main Business and Markets Served
8.3 Siemens Healthcare
8.3.1 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.3.2 Siemens Healthcare Product Introduction, Application and Specification
8.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.3.4 Main Business and Markets Served
8.4 Toshiba
8.4.1 Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.4.2 Toshiba Product Introduction, Application and Specification
8.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.4.4 Main Business and Markets Served
8.5 Hitachi
8.5.1 Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.5.2 Hitachi Product Introduction, Application and Specification
8.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.5.4 Main Business and Markets Served
8.6 Carestream
8.6.1 Carestream Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.6.2 Carestream Product Introduction, Application and Specification
8.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.6.4 Main Business and Markets Served
8.7 Esaote
8.7.1 Esaote Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.7.2 Esaote Product Introduction, Application and Specification
8.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.7.4 Main Business and Markets Served
8.8 Shimadzu
8.8.1 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.8.2 Shimadzu Product Introduction, Application and Specification
8.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.8.4 Main Business and Markets Served
8.9 TriFoil Imaging
8.9.1 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.9.2 TriFoil Imaging Product Introduction, Application and Specification
8.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.9.4 Main Business and Markets Served
8.10 Biosensors International Group, Ltd
8.10.1 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.10.2 Biosensors International Group, Ltd Product Introduction, Application and Specification
8.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Nuclear Medicine & Radio Pharmaceuticals Market
9.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Trend Analysis
9.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size (Volume and Value) Forecast 2021-2027
9.2 Nuclear Medicine & Radio Pharmaceuticals Regional Market Trend
9.2.1 North America Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.2 Europe Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.3 China Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.4 Japan Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.5 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.6 India Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.3 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Product Type)
9.4 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Nuclear Medicine & Radio Pharmaceuticals Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Nuclear Medicine & Radio Pharmaceuticals
Table Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) Growth Rate Comparison by Types (2016-2027)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Types in 2020
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Product Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Product Picture
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Comparison by Applications (2016-2027)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Applications in 2020
Figure Diagnostic Applications: SPECT, PET.
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) (2016-2027)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) (2016-2027)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure China Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure India Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Table Nuclear Medicine & Radio Pharmaceuticals Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals in 2020
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Industry Chain Structure of Nuclear Medicine & Radio Pharmaceuticals
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Nuclear Medicine & Radio Pharmaceuticals Manufacturing Plants Distribution
Table Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) of Major Manufacturers (2016-2021)
Table Nuclear Medicine & Radio Pharmaceuticals Production (K Units) of Major Manufacturers (2016-2021)
Table Nuclear Medicine & Radio Pharmaceuticals Production Market Share of Major Manufacturers (2016-2021)
Figure Nuclear Medicine & Radio Pharmaceuticals Production Share by Manufacturers in 2020
Table Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) of Major Manufacturers (2016-2021)
Table Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share of Major Manufacturers (2016-2021)
Figure Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers in 2020
Table Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Major Manufacturers (2016-2021)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production by Regions 2016-2021 (K Units)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Regions 2016-2021
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Regions in 2020
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions 2016-2021 (Million USD)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions 2016-2021
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions in 2020
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Regions 2016-2021 (K Units)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Regions 2016-2021
Figure North America Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table North America Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure China Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table China Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure India Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table India Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Global Consumption Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2016-2021)
Figure Global Value (Consumption) Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2016-2021)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2021)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2016-2021)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2016-2021)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2016-2021)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2021)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2016-2021)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2016-2021)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2016-2021)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2021)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2016-2021)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2016-2021)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2016-2021)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Toshiba Nuclear Medicine & Radio Pharm

Nuclear Medicine & Radio Pharmaceuticals Market Segments


Nuclear Medicine & Radio Pharmaceuticals Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Diagnostic Medicine: SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Medicine: Beta Emitters
  • Alpha Emitters
  • Brachytherapy Isotopes

Nuclear Medicine & Radio Pharmaceuticals Application Outlook (Revenue, USD Million, 2021 2027)


  • Diagnostic Applications: SPECT
  • PET.
  • Therapeutic Applications: Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors and Other Therapeutic Applications.

Nuclear Medicine & Radio Pharmaceuticals Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

  • Europe
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

  • Asia Pacific
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

  • Latin America
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

  • Middle East & Africa
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Nuclear Medicine & Radio Pharmaceuticals Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Nuclear Medicine & Radio Pharmaceuticals Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Nuclear Medicine & Radio Pharmaceuticals Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Nuclear Medicine & Radio Pharmaceuticals Market product affairs. The report is at risk of project regarding this Nuclear Medicine & Radio Pharmaceuticals Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthcare
  • Toshiba
  • Hitachi
  • Carestream
  • Esaote
  • Shimadzu
  • TriFoil Imaging
  • Biosensors International Group Ltd

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Nuclear Medicine & Radio Pharmaceuticals related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Nuclear Medicine & Radio Pharmaceuticals Market

Nuclear Medicine & Radio Pharmaceuticals Market

Report Highlights:


The Nuclear Medicine & Radio Pharmaceuticals Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Nuclear Medicine & Radio Pharmaceuticals Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Nuclear Medicine & Radio Pharmaceuticals Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Nuclear Medicine & Radio Pharmaceuticals Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Nuclear Medicine & Radio Pharmaceuticals marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Nuclear Medicine & Radio Pharmaceuticals market using a bottom-up approach, wherein manufacturers value data for different type (Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals, Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes), of Nuclear Medicine & Radio Pharmaceuticals market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Nuclear Medicine & Radio Pharmaceuticals Market

Nuclear Medicine & Radio Pharmaceuticals Market

Key Target Audience:


  • Nuclear Medicine & Radio Pharmaceuticals market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Nuclear Medicine & Radio Pharmaceuticals market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Nuclear Medicine & Radio Pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Nuclear Medicine & Radio Pharmaceuticals market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Diagnostic Medicine: SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Medicine: Beta Emitters
  • Alpha Emitters
  • Brachytherapy Isotopes

By end-user also classify into, the Global Nuclear Medicine & Radio Pharmaceuticals market:


Global Nuclear Medicine & Radio Pharmaceuticals market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Diagnostic Applications: SPECT
  • PET.
  • Therapeutic Applications: Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors and Other Therapeutic Applications.

Highlights of this 2021-2027 Nuclear Medicine & Radio Pharmaceuticals Market Report:

  • Market dynamics, Nuclear Medicine & Radio Pharmaceuticals economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Nuclear Medicine & Radio Pharmaceuticals industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Nuclear Medicine & Radio Pharmaceuticals Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Nuclear Medicine & Radio Pharmaceuticals businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Nuclear Medicine & Radio Pharmaceuticals market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
Table of Contents

Executive Summary
1 Industry Overview of Nuclear Medicine & Radio Pharmaceuticals
1.1 Definition of Nuclear Medicine & Radio Pharmaceuticals
1.2 Nuclear Medicine & Radio Pharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Comparison by Types (2016-2027)
1.2.2 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
1.2.3 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.3 Nuclear Medicine & Radio Pharmaceuticals Segment by Applications
1.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Comparison by Applications (2016-2027)
1.3.2 Diagnostic Applications: SPECT, PET.
1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.4 Global Nuclear Medicine & Radio Pharmaceuticals Overall Market
1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue (2016-2027)
1.4.2 Global Nuclear Medicine & Radio Pharmaceuticals Production (2016-2027)
1.4.3 North America Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.4 Europe Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.5 China Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.6 Japan Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.7 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)
1.4.8 India Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2016-2027)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals
2.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
2.4 Industry Chain Structure of Nuclear Medicine & Radio Pharmaceuticals

3 Development and Manufacturing Plants Analysis of Nuclear Medicine & Radio Pharmaceuticals
3.1 Capacity and Commercial Production Date
3.2 Global Nuclear Medicine & Radio Pharmaceuticals Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Nuclear Medicine & Radio Pharmaceuticals
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Nuclear Medicine & Radio Pharmaceuticals Production and Capacity Analysis
4.2 Nuclear Medicine & Radio Pharmaceuticals Revenue Analysis
4.3 Nuclear Medicine & Radio Pharmaceuticals Price Analysis
4.4 Market Concentration Degree

5 Nuclear Medicine & Radio Pharmaceuticals Regional Market Analysis
5.1 Nuclear Medicine & Radio Pharmaceuticals Production by Regions
5.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Production by Regions
5.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions
5.2 Nuclear Medicine & Radio Pharmaceuticals Consumption by Regions
5.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.3.1 North America Nuclear Medicine & Radio Pharmaceuticals Production
5.3.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.4 Europe Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.4.1 Europe Nuclear Medicine & Radio Pharmaceuticals Production
5.4.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.5 China Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.5.1 China Nuclear Medicine & Radio Pharmaceuticals Production
5.5.2 China Nuclear Medicine & Radio Pharmaceuticals Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.6 Japan Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.6.1 Japan Nuclear Medicine & Radio Pharmaceuticals Production
5.6.2 Japan Nuclear Medicine & Radio Pharmaceuticals Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.7 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.7.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production
5.7.2 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.8 India Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.8.1 India Nuclear Medicine & Radio Pharmaceuticals Production
5.8.2 India Nuclear Medicine & Radio Pharmaceuticals Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Nuclear Medicine & Radio Pharmaceuticals Import and Export

6 Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Type)
6.1 Global Nuclear Medicine & Radio Pharmaceuticals Production by Type
6.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Type
6.3 Nuclear Medicine & Radio Pharmaceuticals Price by Type

7 Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Application)
7.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Application
7.2 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Application (2016-2021)

8 Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers Analysis
8.1 GE Healthcare
8.1.1 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.1.2 GE Healthcare Product Introduction, Application and Specification
8.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.1.4 Main Business and Markets Served
8.2 Philips Healthcare
8.2.1 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.2.2 Philips Healthcare Product Introduction, Application and Specification
8.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.2.4 Main Business and Markets Served
8.3 Siemens Healthcare
8.3.1 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.3.2 Siemens Healthcare Product Introduction, Application and Specification
8.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.3.4 Main Business and Markets Served
8.4 Toshiba
8.4.1 Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.4.2 Toshiba Product Introduction, Application and Specification
8.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.4.4 Main Business and Markets Served
8.5 Hitachi
8.5.1 Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.5.2 Hitachi Product Introduction, Application and Specification
8.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.5.4 Main Business and Markets Served
8.6 Carestream
8.6.1 Carestream Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.6.2 Carestream Product Introduction, Application and Specification
8.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.6.4 Main Business and Markets Served
8.7 Esaote
8.7.1 Esaote Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.7.2 Esaote Product Introduction, Application and Specification
8.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.7.4 Main Business and Markets Served
8.8 Shimadzu
8.8.1 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.8.2 Shimadzu Product Introduction, Application and Specification
8.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.8.4 Main Business and Markets Served
8.9 TriFoil Imaging
8.9.1 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.9.2 TriFoil Imaging Product Introduction, Application and Specification
8.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.9.4 Main Business and Markets Served
8.10 Biosensors International Group, Ltd
8.10.1 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.10.2 Biosensors International Group, Ltd Product Introduction, Application and Specification
8.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2016-2021)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Nuclear Medicine & Radio Pharmaceuticals Market
9.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Trend Analysis
9.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size (Volume and Value) Forecast 2021-2027
9.2 Nuclear Medicine & Radio Pharmaceuticals Regional Market Trend
9.2.1 North America Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.2 Europe Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.3 China Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.4 Japan Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.5 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.2.6 India Nuclear Medicine & Radio Pharmaceuticals Forecast 2021-2027
9.3 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Product Type)
9.4 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Nuclear Medicine & Radio Pharmaceuticals Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

Nuclear Medicine & Radio Pharmaceuticals Market Segments


Nuclear Medicine & Radio Pharmaceuticals Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Diagnostic Medicine: SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Medicine: Beta Emitters
  • Alpha Emitters
  • Brachytherapy Isotopes

Nuclear Medicine & Radio Pharmaceuticals Application Outlook (Revenue, USD Million, 2021 2027)


  • Diagnostic Applications: SPECT
  • PET.
  • Therapeutic Applications: Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors and Other Therapeutic Applications.

Nuclear Medicine & Radio Pharmaceuticals Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

  • Europe
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

  • Asia Pacific
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

  • Latin America
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

  • Middle East & Africa
    • Nuclear Medicine & Radio Pharmaceuticals market, By Product Type Outlook
      • Diagnostic Medicine: SPECT Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • Therapeutic Medicine: Beta Emitters
      • Alpha Emitters
      • Brachytherapy Isotopes

    • Nuclear Medicine & Radio Pharmaceuticals market, By Application Outlook
      • Diagnostic Applications: SPECT
      • PET.
      • Therapeutic Applications: Thyroid
      • Bone Metastasis
      • Lymphoma
      • Endocrine Tumors and Other Therapeutic Applications.

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables and Figures
Figure Picture of Nuclear Medicine & Radio Pharmaceuticals
Table Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) Growth Rate Comparison by Types (2016-2027)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Types in 2020
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Product Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Product Picture
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Comparison by Applications (2016-2027)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Applications in 2020
Figure Diagnostic Applications: SPECT, PET.
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) (2016-2027)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) (2016-2027)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure China Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Figure India Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2016-2027)
Table Nuclear Medicine & Radio Pharmaceuticals Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals in 2020
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Industry Chain Structure of Nuclear Medicine & Radio Pharmaceuticals
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Nuclear Medicine & Radio Pharmaceuticals Manufacturing Plants Distribution
Table Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) of Major Manufacturers (2016-2021)
Table Nuclear Medicine & Radio Pharmaceuticals Production (K Units) of Major Manufacturers (2016-2021)
Table Nuclear Medicine & Radio Pharmaceuticals Production Market Share of Major Manufacturers (2016-2021)
Figure Nuclear Medicine & Radio Pharmaceuticals Production Share by Manufacturers in 2020
Table Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) of Major Manufacturers (2016-2021)
Table Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share of Major Manufacturers (2016-2021)
Figure Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers in 2020
Table Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Major Manufacturers (2016-2021)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production by Regions 2016-2021 (K Units)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Regions 2016-2021
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Regions in 2020
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions 2016-2021 (Million USD)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions 2016-2021
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions in 2020
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Regions 2016-2021 (K Units)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Regions 2016-2021
Figure North America Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table North America Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure China Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table China Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure India Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2016-2021 (K Units)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2016-2021 (Million USD)
Table India Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Global Consumption Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2016-2021)
Figure Global Value (Consumption) Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2016-2021)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2021)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2016-2021)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2016-2021)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2016-2021)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2021)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2016-2021)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2016-2021)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2016-2021)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2016-2021)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2016-2021)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2016-2021)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2016-2021)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Toshiba Nuclear Medicine & Radio Pharm
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Anti-Allergic Drugs Market

Report Description The Global Anti-Allergic Drugs Market Report provides Insightful information to t

Read More

Cannabis Pharmaceutical Market

Key Industry Insights This report is an extensive study that includes a detailed overview of the Can

Read More

Vaccine Packaging Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More